Imran H Yusuf (I H Yusuf)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 53

Top Topics

Plasmodium Falciparum

Patient Satisfaction

Diabetic Retinopathy

Top Venues

Eye (London, England)

Journal of cataract and refractive surgery

The British journal of dermatology

The New England journal of medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Imran H Yusuf, Ruofan C Han, Susan M Downes, Srilakshmi M Sharma
The incidence, monitoring coverage and clinical characteristics of hydroxychloroquine retinopathy in the United Kingdom. Eye (London, England) (2024)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: A randomized trial of immediate vitrectomy and of intravenous antibiotics for postoperative bacterial endophthalmitis: the endophthalmitis vitrectomy study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy: two-year results from the Diabetic Retinopathy Vitrectomy Study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: A randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia: the RADIANCE study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy: two-year results from the Diabetic Retinopathy Vitrectomy Study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation in patients with proliferative diabetic retinopathy (PDR): the CLARITY study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy (PDR): DRCR.net Protocol S. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Ranibizumab plus panretinal photocoagulation (PRP) versus PRP alone for high-risk proliferative diabetic retinopathy (PDR): the PROTEUS study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Intravitreal aflibercept injection in patients with myopic choroidal neovascularization: the MYRROR study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months: the VICI study. Eye (London, England) (2023)
Peter Kiraly, Charles L Cottriall, Laura J Taylor, Jasleen Kaur Jolly, Jasmina Cehajic-Kapetanovic, Imran H Yusuf, Cristina Martinez-Fernandez de la Camara, Morag Shanks, Susan M Downes, Robert E MacLaren, M Dominik Fischer
Outcomes and Adverse Effects of Voretigene Neparvovec Treatment for Biallelic RPE65 -Mediated Inherited Retinal Dystrophies in a Cohort of Patients from a Single Center. Biomolecules 13 (10) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: A randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia: the RADIANCE study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Comparing the effectiveness of bevacizumab to ranibizumab in patients with exudative age-related macular degeneration: the BRAMD study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation in patients with proliferative diabetic retinopathy (PDR): the CLARITY study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Ranibizumab plus panretinal photocoagulation (PRP) versus PRP alone for high-risk proliferative diabetic retinopathy (PDR): the PROTEUS study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months: the VICI study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy: two-year results from the Diabetic Retinopathy Vitrectomy Study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: the ANCHOR study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation in patients with proliferative diabetic retinopathy (PDR): the CLARITY study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Ranibizumab plus panretinal photocoagulation (PRP) versus PRP alone for high-risk proliferative diabetic retinopathy (PDR): the PROTEUS study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months: the VICI study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation in patients with proliferative diabetic retinopathy (PDR): the CLARITY study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: the ANCHOR study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months: the VICI study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy (PDR): DRCR.net Protocol S. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Comparing the effectiveness of bevacizumab to ranibizumab in patients with exudative age-related macular degeneration: the BRAMD study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy: two-year results from the Diabetic Retinopathy Vitrectomy Study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: A randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia: the RADIANCE study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Ranibizumab plus panretinal photocoagulation (PRP) versus PRP alone for high-risk proliferative diabetic retinopathy (PDR): the PROTEUS study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: the ANCHOR study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Comparing the effectiveness of bevacizumab to ranibizumab in patients with exudative age-related macular degeneration: the BRAMD study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: A randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia: the RADIANCE study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Comparing the effectiveness of bevacizumab to ranibizumab in patients with exudative age-related macular degeneration: the BRAMD study. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy (PDR): DRCR.net Protocol S. Eye (London, England) (2023)
Imran H Yusuf, Christin Henein, Sobha Sivaprasad
Infographic: Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy (PDR): DRCR.net Protocol S. Eye (London, England) (2023)
Imran H Yusuf, Ruofan C Han, Susan M Downes, Srilakshmi M Sharma
A nationwide survey of hydroxychloroquine retinopathy presenting to the hospital eye service in the United Kingdom. Eye (London, England) (2022)
Imran H Yusuf, Artemis Matsou, Florian T A Kretz, Roberto Bellucci
Comment on: Laser corneal enhancement after trifocal intraocular lens implantation in eyes that had previously undergone photoablative corneal refractive surgery. Journal of cataract and refractive surgery 48 (4) (2022)
Imran H Yusuf, Amanda Ie, Ravi Purohit, Sarah Maling, Chetan Kantibhai Patel
Paediatric vitreous haemorrhage secondary to clinically occult, anomalous hyaloid and peripapillary arteries demonstrated by OCT-A. Eye (London, England) 36 (9) (2022)
Imran H Yusuf, Marwan Bukhari, James Galloway, Andrew J Lotery
Baseline retinal testing is no longer recommended for hydroxychloroquine users in the United Kingdom. Rheumatology (Oxford, England) 60 (5) (2021)
Imran H Yusuf, F Latheef, M Ardern-Jones, A J Lotery
New recommendations for retinal monitoring in hydroxychloroquine users: baseline testing is no longer supported. The British journal of dermatology 185 (2) (2021)
Imran H Yusuf, Barny Foot, Andrew John Lotery
The Royal College of Ophthalmologists recommendations on monitoring for hydroxychloroquine and chloroquine users in the United Kingdom (2020 revision): executive summary. Eye (London, England) 35 (6) (2021)
Imran H Yusuf, Artemis Matsou, Damian Lake, Basak Bostanci Ceran, Mayank A Nanavaty
Comment on: Immediately sequential bilateral cataract surgery (ISBCS): an Academic Teaching Center's experience. Journal of cataract and refractive surgery 47 (12) (2021)
Johannes Birtel, Imran H Yusuf, Claudia Priglinger, Günter Rudolph, Peter Charbel Issa
Diagnosis of Inherited Retinal Diseases. Klinische Monatsblatter fur Augenheilkunde 238 (3) (2021)
Basak Bostanci Ceran, Imran H Yusuf, Rushmia Karim, Marie José Tassignon
Comment on: Safety of phakic intraocular collamer lens implantation in 95 highly myopic special-needs children. Journal of cataract and refractive surgery 47 (12) (2021)
Imran H Yusuf, Artemis Matsou, Guy Kleinmann, Jesper O Hjortdal
Comment on: Effect of residual astigmatism on uncorrected visual acuity and patient satisfaction in pseudophakic patients. Journal of cataract and refractive surgery 47 (11) (2021)
Federica E Poli, Imran H Yusuf
Retinopathy in Malignant Hypertension. The New England journal of medicine 385 (21) (2021)
Imran H Yusuf, Robert E MacLaren, Peter Charbel Issa
CDHR1-related late-onset macular dystrophy: further insights. Eye (London, England) 35 (10) (2020)
Laurel C Chandler, Imran H Yusuf, Michelle E McClements, Alun R Barnard, Robert E MacLaren, Kanmin Xue
Immunomodulatory Effects of Hydroxychloroquine and Chloroquine in Viral Infections and Their Potential Application in Retinal Gene Therapy. International journal of molecular sciences 21 (14) (2020)
Imran H Yusuf, A J Lotery, M R Ardern-Jones
Joint recommendations for retinal screening in long-term users of hydroxychloroquine and chloroquine in the United Kingdom, 2018. The British journal of dermatology 179 (4) (2018)
Claudia Worth, Imran H Yusuf, Bethany Turner, Hanae Gourier, Emma E Brooks, Daniel O Mort, Srilakshmi Sharma, Susan M Downes, Raashid A Luqmani
An audit of the use of hydroxychloroquine in rheumatology clinics. Rheumatology advances in practice 2 (1) (2018)